HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 214 | 240 | 89.2% | |
| HF004 | 2020 | 209 | 239 | 87.5% | |
| HF006 | 2021 | 272 | 317 | 85.8% | |
| HF006 | 2022 | 323 | 342 | 94.4% | |
| HF006 | 2023 | 346 | 360 | 96.1% |
